New patent for Gilead Sciences drug BIKTARVY

Annual Drug Patent Expirations for BIKTARVY Biktarvy is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from two suppliers. There are twelve…

Source


Comments are closed.

Biotechblog